Loading...

TSBX TURNSTONE BIOLOGICS CORP Delisting Actions 8-K Filing

TRNS

TSBX

TURNSTONE BIOLOGICS CORP

(TSBX)

2025 8-K

Show Summary

Show Summary

Financial Statements

Stock Delisting

Financial Results

Strategic Alternatives

Workforce Reduction

Nasdaq Compliance Notice

Financial Results

Annual Meeting Results

Financial Results Announcement

Departure of Directors

Earnings Reports

Regulation FD Disclosure

Initial Public Offerings

External Links:

On September 27, 2024, Turnstone Biologics Corp. was notified by Nasdaq that it failed to meet the minimum bid price requirement, leading to a transfer of its stock listing to the Nasdaq Capital Market, effective March 31, 2025, with an additional 18

AI Assistant

TURNSTONE BIOLOGICS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.